Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd Share Price

(KILITCH)

Check the latest share price of Kilitch Drugs (India) Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹400.9

12.09%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Kilitch Drugs (India) Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹362.1
    Day's Price Range
    ₹429.15
  • 52 Week's Low

    52 Week's High

    ₹299.95
    52-Week Price Range
    ₹429.15
1 Month Return+ 3.97 %
3 Month Return-0.74 %
1 Year Return-4.6 %
Previous Close₹357.65
Open₹364.00
Volume3.39L
Upper Circuit-
Lower Circuit-
Market Cap₹536.67Cr

Kilitch Drugs (India) Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹536.67 Cr

Return on Equity (ROE)

6.18

Return on capital employed (ROCE)

7.82

P/B Ratio

1.49

EPS (TTM)

2.43

Sector

Pharmaceuticals

How to invest in Kilitch Drugs (India) Ltd

Investing in Kilitch Drugs (India) Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Kilitch Drugs (India) Ltd or KILITCH on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Kilitch Drugs (India) Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Kilitch Drugs (India) Ltd with just a few clicks!

Kilitch Drugs (India) Ltd Valuation

Track how the P/E of Kilitch Drugs (India) Ltd has moved over time to understand valuation trends.

Kilitch Drugs (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (37.01x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (363.79x)

October 16, 2020

LowHigh

Today’s Price to Earnings Ratio: 37.01x

Kilitch Drugs (India) Ltd Financials

Get the annual and quarterly financial summary of Kilitch Drugs (India) Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹36.56Cr (-)₹41.20Cr (↑12.69%)₹31.79Cr (↓22.84%)₹44.82Cr (↑40.99%)₹33.45Cr (↓25.37%)
Net Income₹3.06Cr (-)₹5.09Cr (↑66.34%)₹1.74Cr (↓65.82%)₹3.68Cr (↑111.49%)₹0.11Cr (↓97.01%)
Net Profit Margin8.37% (-)12.35% (↑47.55%)5.47% (↓55.71%)8.21% (↑50.09%)0.33% (↓95.98%)
Value in ₹ crore
Details2019202020212022
Total Assets₹172.03Cr (-)₹174.12Cr (↑1.21%)₹195.85Cr (↑12.48%)₹232.28Cr (↑18.60%)
Total Liabilities₹20.94Cr (-)₹22.48Cr (↑7.35%)₹32.92Cr (↑46.44%)₹54.25Cr (↑64.79%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow-₹1.32Cr (-)₹7.42Cr (↓662.12%)₹7.29Cr (↓1.75%)₹6.13Cr (↓15.91%)₹5.21Cr (↓15.01%)

Kilitch Drugs (India) Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kilitch Drugs (India) Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
68.25%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
31.75%
0.00
Others
0%
0.00

Kilitch Drugs (India) Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹536.67 Cr41.71%0.55NANA
NA₹917.81 Cr113.16%0.55NANA
NA₹81.01 Cr41.61%0.64NANA
NA₹12.19 Cr-9.37%0.50NANA
BUY₹408.83 Cr182.55%0.55NANA

Kilitch Drugs (India) Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Kilitch Drugs (India) Ltd.

  • Kilitch Drugs Reports Strong Growth and Expansion Plans - 19 Mar, 2025

    Kilitch Drugs Ltd plans to enter biosimilars and expand manufacturing in Maharashtra. The company expects ₹200 crore revenue this year, reporting a 222% YoY profit rise in Q3FY25.

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 36.03 Cr → 57.89 Cr (in ₹), with an average increase of 20.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KILITCH stock has moved up by 1.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 45.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.23% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 30.77% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 54.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 8.62 Cr → 5.96 Cr (in ₹), with an average decrease of 30.9% per quarter

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹33.45Cr as on June 2024 (Q2 24)
Net Profit: ₹0.11Cr as on June 2024 (Q2 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Futures and Options

View the latest movement in Kilitch Drugs (India) Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Kilitch Drugs (India) Ltd price today?

Kilitch Drugs (India) Ltd share price today stands at ₹400.9, Open: ₹364, Previous Close: ₹357.65, High: ₹429.15, Low: ₹362.1, 52 Week High: ₹429.15, 52 Week Low: ₹299.95.

How to Buy Kilitch Drugs (India) Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Kilitch Drugs (India) Ltd shares

What are today's traded volumes of Kilitch Drugs (India) Ltd?

Today's traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 3.39L.

What is today's market capitalisation of Kilitch Drugs (India) Ltd?

Today's market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹536.67 Cr.

What is the 52 Week High and Low Range of Kilitch Drugs (India) Ltd?

Kilitch Drugs (India) Ltd (KILITCH)
Price
52 Week High
₹429.15
52 Week Low
₹299.95

How much percentage Kilitch Drugs (India) Ltd is down from its 52 Week High?

Kilitch Drugs (India) Ltd (KILITCH) share price is ₹400.9. It is down -6.58% from its 52 Week High price of ₹429.15

How much percentage Kilitch Drugs (India) Ltd is up from its 52 Week low?

Kilitch Drugs (India) Ltd (KILITCH) share price is ₹400.9. It is up 33.66% from its 52 Week Low price of ₹299.95